We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.27B
AUM Growth
+$54.2M
Cap. Flow
+$6.03M
Cap. Flow %
0.47%
Top 10 Hldgs %
30.4%
Holding
230
New
24
Increased
67
Reduced
66
Closed
9

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$16.4M
2
TWX
Time Warner Inc
TWX
+$13.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.56M
4
TSN icon
Tyson Foods
TSN
+$7.59M
5
QCOM icon
Qualcomm
QCOM
+$7.49M

Sector Composition

Rank Sector Weight
1 Technology 22.68%
2 Financials 19.47%
3 Healthcare 12.46%
4 Communication Services 9.96%
5 Industrials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
101
MetLife
MET
$62.1B
$1.74M 0.14%
34,455
+1,400
+4% +$73.7K
HES
102
DELISTED
Hess
HES
$1.61M 0.13%
33,985
-1,890
-5% -$85.3K
GILD icon
103
Gilead Sciences
GILD
$166B
$1.57M 0.12%
21,980
+2,709
+14% +$206K
YORW icon
104
York Water
YORW
$514M
$1.55M 0.12%
45,690
MRK icon
105
Merck
MRK
$317B
$1.54M 0.12%
28,730
-1,310
-4% -$72.6K
EBAY icon
106
eBay
EBAY
$50.1B
$1.54M 0.12%
40,733
+8,528
+26% +$317K
BMY icon
107
Bristol-Myers Squibb
BMY
$131B
$1.48M 0.12%
24,195
-110
-0.5% -$6.88K
ESND
108
DELISTED
Essendant Inc.
ESND
$1.4M 0.11%
150,450
-133,475
-47% -$1.37M
APD icon
109
Air Products & Chemicals
APD
$67.2B
$1.39M 0.11%
8,470
+1,204
+17% +$192K
MO icon
110
Altria Group
MO
$114B
$1.36M 0.11%
19,067
-125
-0.7% -$8.38K
MUB icon
111
iShares National Muni Bond ETF
MUB
$45.4B
$1.36M 0.11%
12,272
DGX icon
112
Quest Diagnostics
DGX
$26.3B
$1.34M 0.11%
13,641
-12,112
-47% -$1.15M
HD icon
113
Home Depot
HD
$351B
$1.26M 0.1%
6,637
IBM icon
114
IBM
IBM
$222B
$1.21M 0.09%
8,213
-3,121
-28% -$454K
MDLZ icon
115
Mondelez International
MDLZ
$80.1B
$1.2M 0.09%
28,061
-1,700
-6% -$71.4K
SO icon
116
Southern Company
SO
$107B
$1.11M 0.09%
23,148
PEP icon
117
PepsiCo
PEP
$189B
$1.11M 0.09%
9,263
-250
-3% -$28.5K
VEU icon
118
Vanguard FTSE All-World ex-US ETF
VEU
$68.3B
$1.09M 0.09%
+20,000
New +$1.08M
NEE icon
119
NextEra Energy
NEE
$178B
$1.07M 0.08%
27,464
BEN icon
120
Franklin Resources
BEN
$17.1B
$1.06M 0.08%
+24,500
New +$1.06M
PNC icon
121
PNC Financial Services
PNC
$101B
$1.06M 0.08%
7,350
D icon
122
Dominion Energy
D
$59.3B
$1.01M 0.08%
12,504
+200
+2% +$16.2K
RTX icon
123
RTX Corp
RTX
$299B
$920K 0.07%
11,455
-10,456
-48% -$794K
OXY icon
124
Occidental Petroleum
OXY
$56.3B
$886K 0.07%
12,022
-422
-3% -$28.6K
SPTI icon
125
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
$884K 0.07%
29,750

Similar funds

Philadelphia Trust Company's Q4 2017 Portfolio in Review

As of Q4 2017, Philadelphia Trust Company held 230 positions worth $1.27B, up 4.5% from $1.22B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Philadelphia Trust Company's Q4 2017 filing shows 24 new, 67 increased, 66 reduced and 9 closed positions. Its largest new stake was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 175,285 shares worth $6M. The largest sale was CVS Health, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Philadelphia Trust Company's largest Q4 2017 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 175,285 shares worth $6M.
  • Philadelphia Trust Company added most to Emerson Electric in Q4 2017, an estimated $10.5M increase.
  • Philadelphia Trust Company's biggest Q4 2017 reduction was CVS Health, cutting an estimated $16.4M.
  • Philadelphia Trust Company fully exited Regeneron Pharmaceuticals in Q4 2017, selling an estimated $8.56M.
  • Philadelphia Trust Company's ten largest holdings make up 30% of its $1.27B portfolio in Q4 2017.
  • Philadelphia Trust Company opened 24 new positions and closed 9 in Q4 2017.
  • Philadelphia Trust Company's portfolio value rose 4.5% quarter-over-quarter to $1.27B.

Based on Philadelphia Trust Company's 13F filing for Q4 2017, filed 14 Feb 2018.